Ocuphire Pharma, Inc.
11Patents
11Active
11Granted
54Portfolio score
Filing activity: Sep 25, 2017 → Dec 30, 2022
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10278918B2 | Aqueous ophthalmic solutions of phentolamine and medical uses thereof | Human Necessities | 14 | Active |
| US10772829B2 | Aqueous ophthalmic solutions of phentolamine and medical uses thereof | Human Necessities | 10 | Active |
| US11000509B2 | Methods and compositions for daily ophthalmic administration of phentolamine to improve visual performance | Human Necessities | 8 | Active |
| US11090261B2 | Aqueous ophthalmic solutions of phentolamine and medical uses thereof | Human Necessities | 7 | Active |
| US10993932B2 | Methods and compositions for treatment of presbyopia, mydriasis, and other ocular disorders | Human Necessities | 6 | Active |
| US11844858B2 | Aqueous ophthalmic solutions of phentolamine and medical uses thereof | Human Necessities | 4 | Active |
| US11717510B2 | Methods and compositions for daily ophthalmic administration of phentolamine to improve visual performance | Human Necessities | 4 | Active |
| US11400077B2 | Methods and compositions for treatment of presbyopia, mydriasis, and other ocular disorders | Human Necessities | 4 | Active |
| US11566005B2 | Highly pure phentolamine mesylate and methods for making same | Human Necessities | 4 | Active |
| US11976044B2 | Highly pure phentolamine mesylate | Human Necessities | 2 | Active |
| US12016841B2 | Methods and compositions for treatment of presbyopia, mydriasis, and other ocular disorders | Human Necessities | 2 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.